April 19 (SeeNews) - Serbian state-owned drug maker Galenika narrowed its net loss to 5.6 billion dinars ($65.6 million/50.2 million euro) in 2012 from 13.5 billion dinars a year earlier, data from the country's Business Registry Agency (APR) indicated.